QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 oppenheimer-downgrades-edwards-lifesciences-to-perform

Oppenheimer analyst Suraj Kalia downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Perform.

 evercore-isi-group-upgrades-edwards-lifesciences-to-outperform-raises-price-target-to-88

Evercore ISI Group analyst Vijay Kumar upgrades Edwards Lifesciences (NYSE:EW) from In-Line to Outperform and raises the pri...

 heres-how-much-you-would-have-made-owning-edwards-lifesciences-stock-in-the-last-20-years

Edwards Lifesciences (NYSE: EW) has outperformed the market over the past 20 years by 7.57% on an annualized basis producing an...

 stifel-maintains-buy-on-edwards-lifesciences-lowers-price-target-to-85

Stifel analyst Rick Wise maintains Edwards Lifesciences (NYSE:EW) with a Buy and lowers the price target from $95 to $85.

 israel-englanders-millennium-goes-all-in-on-crypto-and-healthcare-while-rebalancing-big-tech-bets-bitcoin-etf-and-palantir-stakes-soar-in-q2

Millennium Management's Q2 2025 13F reveals big bets on crypto (IBIT, PLTR) & healthcare (EW, INSM), with tech rebalanc...

 deal-dispatch-performance-food-group-and-claires-lead-a-week-of-big-auctions-retail-woes

Performance Food rejects offer; Lufthansa drops Air Europa bid; NFL inks deal with ESPN; Claire's files bankruptcy amid ret...

 ftc-sounds-alarm-on-edwards-attempt-to-corner-heart-device-market

The FTC complaint alleges that if Edwards acquires JenaValve, it would gain control over the two most advanced TAVR-AR devices.

 wells-fargo-maintains-overweight-on-edwards-lifesciences-raises-price-target-to-88

Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target f...

 edwards-lifesciences-provides-comments-on-ftcs-action-to-block-proposed-acquisition-of-jenavalve-disagrees-with-ftcs-decision-and-believes-it-will-limit-the-availability-of-an-important-treatment-option-for-patients-suffering-from-aortic-regurgitation-intends-to-continue-to-pursue-regulatory-approval-of-the-acquisition-and-estimates-a-final-determination-by-the-end-of-q1-2026-increases-its-adjusted-eps-guidance-for-the-fy-to-the-high-end-of-245-255-up-from-the-high-end-of-240-250

Edwards Lifesciences (NYSE:EW) announced today that the U.S. Federal Trade Commission (FTC) moved to block the company's pr...

 edwards-lifesciences-stock-likely-to-see-sluggish-price-action-through-2027

Edwards Lifesciences may avoid bearishness but is likely to trade sluggishly through 2027, as key cycle phases signal limited u...

 jp-morgan-maintains-neutral-on-edwards-lifesciences-raises-price-target-to-85

JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences (NYSE:EW) with a Neutral and raises the price target from $80...

 canaccord-genuity-maintains-hold-on-edwards-lifesciences-raises-price-target-to-81

Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target ...

 edwards-lifesciences-lifts-2025-outlook-on-strong-first-half-performance

Edwards Lifesciences beat Q2 estimates and raised its 2025 sales outlook as TAVR and TMTT segments drove double-digit revenue g...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION